| 000 | 01003 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514040734.0 | ||
| 264 | 0 | _c20030210 | |
| 008 | 200302s 0 0 eng d | ||
| 022 | _a1473-7159 | ||
| 024 | 7 |
_a10.1586/14737159.2.4.337 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLakkis, Maha M | |
| 245 | 0 | 0 |
_aApplication of toxicogenomics to drug development. _h[electronic resource] |
| 260 |
_bExpert review of molecular diagnostics _cJul 2002 |
||
| 300 |
_a337-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aGene Expression Profiling _xinstrumentation |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 | _aPharmacogenetics |
| 700 | 1 | _aDeCristofaro, Marc F | |
| 700 | 1 | _aAhr, Hans J | |
| 700 | 1 | _aMansfield, Traci A | |
| 773 | 0 |
_tExpert review of molecular diagnostics _gvol. 2 _gno. 4 _gp. 337-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/14737159.2.4.337 _zAvailable from publisher's website |
| 999 |
_c12026423 _d12026423 |
||